Upload Avatar (500 x 500)
Yueyin Pan
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: Chinese, English
Anti-Tumor Drugs
Efficacy Prediction
Resistance Mechanisms
Cancer Treatment
Drug Development
Oncology
Pharmacology
Clinical Research
Biomarkers
Personalized Medicine
Areas of Focus
- Research on the efficacy prediction and resistance mechanisms of anti-tumor drugs
Work Experience
- 2016.07-present - University of Science and Technology of China First Affiliated Hospital West District - Vice President
- 2007.12-2016.07 - Anhui Medical University First Affiliated Hospital - Chief Physician in Oncology
- 2007.11-2008.10 - Harvard Medical School, BWH/DANA-FARBER - Visiting Scholar
- 1987.09-2007.12 - Anhui Medical University First Affiliated Hospital - Resident Physician, Attending Physician, Associate Chief Physician
Academic Background & Achievements
- 2003.09–2007.07 PhD in Clinical Pharmacology: Anhui Medical University
- 1997.09–2000.07 Master's in Public Health: Anhui Medical University
- 1982.09–1987.07 Bachelor's: Wannan Medical College
- State Council Special Allowance Expert
- Jianghuai Famous Doctor
Publications
- Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping, Jin W, Shan B, Liu H, Zhou S, Li W, Pan J, Lin L, Hu D, Pan Y*, 2019
- Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath, Shan B, Broza YY, Li W, Wang Y, Wu S, Liu Z, Wang J, Gui S, Wang L, Zhang Z, Liu W, Zhou S, Jin W, Zhang Q, Hu D, Lin L, Zhang Q, Li W, Wang J, Liu H, Pan Y*, Haick H*, 2020
- Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity, Huang Y#, Wang H, Hao Y, Lin H, Dong M, Ye J, Song L, Wang Y, Li Q, Shan B, Jiang Y, Li H, Shao Z, Kroemer G, Zhang H, Bai L, Jin T, Wang C, Ma Y, Cai Y, Ding C, Liu S*, Pan Y*, Jiang W*, Zhou R*, 2020
- Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy, Yin W#, Ke W, Lu N, Wang Y, Japir AAMM, Mohammed F, Wang Y, Pan Y*, Ge Z*, 2020
- An artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients, Chen J, QianX, He Y, Han X, Pan Y*, 2021
- Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study, Jie Zhang#, Yueyin Pan#, Qin Shi#, Guojun Zhang#, Liyan Jiang, Xiaorong Dong, Kangsheng Gu, Huijuan Wang, Xiaochun Zhang, Nong Yang, Yuping Li, Jianping Xiong, Tienan Yi, Min Peng, Yong Song, Yun Fan, Jiuwei Cui, Gongyan Chen, Wei Tan, Aimin Zang, Qisen Guo, Guangqiang Zhao, Ziping Wang, Jianxing He, Wenxiu Yao, Xiaohong Wu, Kai Chen, Xiaohua Hu, Chunhong Hu, Lu Yue, Da Jiang, Guangfa Wang, Junfeng Liu, Guohua Yu, Junling Li, Jianling Bai, Wenmin Xie, Weihong Zhao, Lihong Wu, Caicun Zhou, 2022
- Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study, Yao Y, Wang Y, Du Y, Jiang F, Liang H, Bi M, Xie H, Peng W, Pan Y, 2023
Awards
- Anhui Science and Technology Award (2021): First Prize
